Impella

The top 15 cardiovascular device makers included in the most recent Medtech 100 rankings are on track to return to their pre-pandemic growth rates and strategies by the end of 2022, but COVID-19 has

The top 15 cardiovascular device makers included in the most recent Medtech 100 rankings are on track to return to their pre-pandemic growth rates and strategies by the end of 2022, but COVID-19 has h

Netherlands-based venture capital firm Forbion Capital Partners has launched a new €92 milion ($116 million) life science fund to invest in 12 to 15 new companies. This is first close for the new fund

The past year witnessed two milestones in structural heart disease: the first US approval of a transcatheter aortic heart valve – the Sapien valve from Edwards Lifesciences Corp. – and the compl